InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Coherus BioSciences stock is rising on Monday as CHRS investors react to a $170 million divestment of its CIMERLI ophthalmology franchise.
The post Why Is Coherus BioSciences (CHRS) Stock Up 17% Today? appeared first on InvestorPlace.
More From InvestorPlace